A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

NCT01426789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Placebo
DRUG: Secukinumab

Sponsor

Novartis Pharmaceuticals